POLAKOVA, Katerina Machova, Ali ALBEER, Vaclava POLIVKOVA, Monika KRUTSKA, Katerina VLCANOVA, Nikola CURIK, Alice FABARIUS, Hana KLAMOVA, Birgit SPIESS, Cornelius F WALLER, Tim H BRUEMMENDORF, Jolanta DENGLER, Volker KUNZMANN, Andreas BURCHERT, Petra BELOHLAVKOVA, Satu MUSTJOKI, Edgar FABER,
Jiří MAYER,
Daniela ŽÁČKOVÁ, Panayiotis PANAYIOTIDIS, Johan RICHTER, Henrik HJORTH-HANSEN, Magdalena KAMINSKA, Magdalena PLONKA, Elzbieta SZCZEPANEK, Monika SZAREJKO, Grazyna BOBER, Iwona HUS, Olga GRZYBOWSKA-IZYDORCZYK, Ewa WASILEWSKA, Edyta PACZKOWSKA, Joanna NIESIOBEDZKA-KREZEL, Krzysztof GIANNOPOULOS, Francois X MAHON, Tomasz SACHA, Susanne SAUSSELE and Markus PFIRRMANN. The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
Leukemia. London: Nature Publishing Group, 2024, 8 pp. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-023-02109-2.